Author:
Galaris Georgios,Thalgott Jérémy H.,Lebrin Franck P. G.
Publisher
Springer International Publishing
Reference135 articles.
1. Abdalla, S. A., & Letarte, M. (2006). Hereditary haemorrhagic telangiectasia: Current views on genetics and mechanisms of disease. Journal of Medical Genetics, 43(2), 97–110.
https://doi.org/10.1136/jmg.2005.030833
.
2. Alam MA, Sami S, Babu S (2011) Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide. BMJ Case Rep 2011. https://doi.org/10.1136/bcr.08.2011.4585.
3. Al-Samkari, H., Kritharis, A., Rodriguez-Lopez, J. M., & Kuter, D. J. (2019). Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. Journal of Internal Medicine, 285(2), 223–231.
https://doi.org/10.1111/joim.12832
.
4. Albinana V, Sanz-Rodriguez F, Recio-Poveda L, Bernabeu C, Botella LM (2011) Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-beta1 signaling in endothelial cells. Mol Pharmacol 79 (5):833–843.
https://doi.org/10.1124/mol.110.067447
5. Ardelean, D. S., Yin, M., Jerkic, M., Peter, M., Ngan, B., Kerbel, R. S., Foster, F. S., & Letarte, M. (2014). Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis. Angiogenesis, 17(3), 641–659.
https://doi.org/10.1007/s10456-014-9421-x
.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献